Matinas BioPharma Holdings, Inc. (OTC: MTNB) announced that it has commenced dosing in the Phase 1 clinical study of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE